Novo Nordisk shares dropped as much as 17% Tuesday after the obesity drugmaker cut its full-year sales and profit outlook for ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, ...

Discover the rise of "Ozempic face" linked to weight loss drugs like semaglutide, its cosmetic effects, and treatments like ...

Ozempic users are reporting unexpected hair loss, potentially linked to rapid weight loss and nutrient deficiencies, raising questions about the broader side effects of semaglutide medications.

In this week’s edition of InnovationRx, we look at Halle Berry’s menopause startup, Ambience Healthcare’s $243 million ...

The Fed kept rates steady, as most economists had expected, but struck a more hawkish tone, causing a mid-afternoon stock sell-off.

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Aggressive social media marketing by influencers has fuelled a surge in over-the-counter use of the diabetes and obesity ...

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.